1,313 results on '"Schröder, Fritz H."'
Search Results
2. Prostate Cancer
3. Prevention and early detection of prostate cancer
4. What explains the differences between centres in the European screening trial? A simulation study
5. Supplementary Table 1 from Evidence of Limited Contributions for Intratumoral Steroidogenesis in Prostate Cancer
6. Supplementary Table 3 from Evidence of Limited Contributions for Intratumoral Steroidogenesis in Prostate Cancer
7. Supplementary Table 2 from Evidence of Limited Contributions for Intratumoral Steroidogenesis in Prostate Cancer
8. Data from Evidence of Limited Contributions for Intratumoral Steroidogenesis in Prostate Cancer
9. Relationship Between Baseline Prostate-specific Antigen on Cancer Detection and Prostate Cancer Death:Long-term Follow-up from the European Randomized Study of Screening for Prostate Cancer
10. ERSPC, PLCO Studies and Critique of Cochrane Review 2013
11. Screening for Prostate Cancer: Current Status of ERSPC and Screening-Related Issues
12. Screening for prostate cancer
13. Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up
14. Editorial: Priorities in Future Research in prostate Cancer Screening
15. The European Randomized Study of Screening for Prostate Cancer (ERSPC)
16. Review of Diagnostic Markers for Prostate Cancer 16
17. Active surveillance for low-risk prostate cancer
18. Steroidal Antiandrogens
19. The European Randomized Study of Screening for Prostate Cancer (ERSPC)
20. Testosterone treatment is not associated with increased risk of prostate cancer or worsening of lower urinary tract symptoms: prostate health outcomes in the Registry of Hypogonadism in Men
21. ERG immunohistochemistry is not predictive for PSA recurrence, local recurrence or overall survival after radical prostatectomy for prostate cancer
22. Cyproterone Acetate — Results of Clinical Trials and Indications for Use in Human Prostate Cancer
23. Remarks on Screening and Early Detection of Prostate Cancer
24. Prostate Cancer
25. Intermittent versus continuous cyproterone acetate in bone metastatic prostate cancer: results of a randomized trial
26. Evaluating the Prostate Cancer Prevention Trial High Grade prostate cancer risk calculator in 10 international biopsy cohorts: results from the prostate biopsy collaborative group
27. Prostate cancer around the world. An overview
28. Antiandrogens in the Treatment of Prostate Cancer
29. Androgens and carcinoma of the prostate
30. PD13-04 PROSTATE CANCER SPECIFIC MORTALITY IN THE ERSPC TRIAL: WHAT IS THE ROLE OF SCREENING RESULT AND ADHERENCE
31. Do Treatment Differences between Arms Affect the Main Outcome of ERSPC Rotterdam?
32. A longitudinal study on the impact of active surveillance for prostate cancer on anxiety and distress levels
33. Erectile Dysfunction and Mental Health in a General Population of Older Men
34. Early Versus Delayed Endocrine Treatment of T2-T3 pN1-3 M0 Prostate Cancer Without Local Treatment of the Primary Tumour: Final Results of European Organisation for the Research and Treatment of Cancer Protocol 30846 After 13 Years of Follow-up (A Randomised Controlled Trial)
35. Outcomes of Men with Screen-Detected Prostate Cancer Eligible for Active Surveillance Who Were Managed Expectantly
36. Digital Rectal Examination and the Diagnosis of Prostate Cancer—a Study Based on 8 Years and Three Screenings within the European Randomized Study of Screening for Prostate Cancer (ERSPC), Rotterdam
37. A Framework for the Identification of Men at Increased Risk for Prostate Cancer
38. ERSPC, PLCO Studies and Critique of Cochrane Review 2013
39. Screening for Prostate Cancer: Current Status of ERSPC and Screening-Related Issues
40. Evaluating the PCPT risk calculator in ten international biopsy cohorts: results from the Prostate Biopsy Collaborative Group
41. Prostate-Specific Antigen Kinetics in Clinical Decision-Making During Active Surveillance for Early Prostate Cancer—A Review
42. The Role of the Digital Rectal Examination in Subsequent Screening Visits in the European Randomized Study of Screening for Prostate Cancer (ERSPC), Rotterdam
43. Progress in Understanding Androgen-Independent Prostate Cancer (AIPC): A Review of Potential Endocrine-Mediated Mechanisms
44. Is It Necessary to Detect All Prostate Cancers in Men with Serum PSA Levels
45. Early Detection of Prostate Cancer in 2007: Part 1: PSA and PSA Kinetics
46. Screening for prostate cancer (PC)—an update on recent findings of the European Randomized Study of Screening for Prostate Cancer (ERSPC)
47. Overall Survival in the Intervention Arm of a Randomized Controlled Screening Trial for Prostate Cancer Compared with a Clinically Diagnosed Cohort
48. Does “Normal” Aging Imply Urinary, Bowel, and Erectile Dysfunction? A General Population Survey
49. RE: Prostate-Specific Antigen Screening Trials and Prostate Cancer Deaths: The Androgen Deprivation Connection
50. Validation of stem cell markers in clinical prostate cancer: α6-Integrin is predictive for non-aggressive disease
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.